You are here: Industry Insights > DNA

News List

SPARC inks research collaboration pact with China’s HitGen expressbpd
March 13, 2019
Under the terms of the agreement, HitGen will receive upfront payment and will be eligible for certain milestone payments
Hands Don't Spread HPV, Study Finds drugs
February 18, 2019
Human papillomavirus (HPV) is easily transmitted during sex, but it is unlikely to be passed by the hands, Canadian researchers report....
Using water and gold, Australian researchers discover ‘universal cancer biomarker’ fiercebiotech
January 02, 2019
Australian researchers at the University of Queensland have discovered a unique DNA structure that appears to be shared by many cancers and could be used to .....
DNA Origami full of potent anticancer agents worldpharmanews
November 30, 2018
One of the most successful techniques to combat multidrug resistance in cancer cells is the downregulation of those genes responsible for drug resistance.
Invectys raises €15M for DNA cancer vaccine study in CLL fiercepharma
November 28, 2018
French startup Invectys hopes its cancer vaccine can win a spot in immuno-oncology combination therapies, and it just nabbed €15 million ($17 million) in series A funding to support that ambition.
HitGen, Biogen initiate drug discovery collaboration pharmatimes
November 26, 2018
HitGen Ltd has announced that the company has entered into a drug discovery research collaboration with Biogen to identify novel small molecule leads for targets of interest.
HitGen and Biogen enter a DNA-Encoded Library-Based Drug Discovery Research Collaboration pharmafocusasia
November 26, 2018
HitGen Ltd announced that the company has entered into a drug discovery research collaboration with Biogen to identify novel small molecule leads for targets...
Natera Signs Agreement with Bristol-Myers Squibb americanpharmaceuticalreview
September 18, 2018
Natera announced an agreement with Bristol-Myers Squibb to use Natera's Signatera custom circulating tumor DNA assay in a Phase 2 study in the adjuvant...
Inhaled blood pressure drug shows promise in treating anxiety and pain europeanpharmaceuticalreview
September 18, 2018
The inhaled version of a high blood pressure drug may treat some types of anxiety and pain, reveals new research from the Centre for Addiction and Mental Health…
ViroMed Secures DNA Production Facility in the U.S. contractpharma
August 22, 2018
ViroMed has acquired a plasmid DNA production facility in San Diego, CA from Vical Incorporated. With ViroMed's first Phase III clinical trial of its lead product VM202 (donaperminogene seltoplasmid) for painful diabetic peripheral neuropathy (PDPN) neari

Previous page 1 2 3 4 5 6 7 8 9 Next page